Tirzepatide is a promising new drug belonging to the GLP-1 and GIP Receptor Agonist classes of drugs that has recently been approved by the US Food and Drug Administration (FDA) for the treatment of type 2 diabetes. It appears as an alternative to Ozempic (Semaglutide), which has rapidly become a popular weight-loss medication among […]Read More
Semaglutide is perhaps the most popular and widely used GLP-1 Agonist on the market, but before I explain what it does, allow me to explain GLP-1 Agonists as a whole… WHAT ARE GLP-1 AGONISTS? GLP-1 Agonists (also known as Incretin Mimetics) are a class of meds that mimic the actions of GLP-1 (Glucagon-Like Peptide 1), […]Read More
© 2024 Steroidify. All rights reserved. Privacy Policy. Contact Us.
